Drug interactions
Buprenorphine subdermal implant + Octreotide
Severity: Moderate
Buprenorphine subdermal implant and Octreotide: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Buprenorphine can prolong the QT interval, and octreotide may add to this through bradycardia and repolarization effects. The overall clinical risk is modest but relevant in patients with other arrhythmia risk factors.
What this interaction means in plain words
Buprenorphine subdermal implant and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Additive QTc prolongation.
What to do
Monitor ECG and heart rate in patients with cardiac disease or electrolyte abnormalities, and correct potassium and magnesium.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Buprenorphine subdermal implant and Octreotide, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Octreotide
Frequently asked questions
Can I take Buprenorphine subdermal implant with Octreotide?
MediHelp rates the interaction as moderate. Buprenorphine subdermal implant and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Buprenorphine can prolong the QT interval, and octreotide may add to this through bradycardia and repolarization effects. The overall clinical risk is modest but relevant in patients with other arrhythmia risk factors.
How serious is the interaction between Buprenorphine subdermal implant and Octreotide?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG and heart rate in patients with cardiac disease or electrolyte abnormalities, and correct potassium and magnesium.
What other medicines interact with Octreotide?
MediHelp also lists interactions of Octreotide with, for example, Adagrasib, Amisulpride, Arsenic trioxide. The full list is on the Octreotide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
